Skip to main content
Top
Published in: Thrombosis Journal 1/2021

Open Access 01-12-2021 | Cyanosis | Case report

Superior vena cava syndrome after pacemaker implantation treated with direct oral anticoagulation

Authors: Nicola Mumoli, Antonino Mazzone, Isabella Evangelista, Marco Cei, Alessandra Colombo

Published in: Thrombosis Journal | Issue 1/2021

Login to get access

Abstract

Background

Superior Vena Cava (SVC) syndrome, is a quite rare but serious complication after pacemaker lead implantation; most patients are asymptomatic due to the development of adequate venous collateral circulation.

Case presentation

We report a case of a 75-year-old woman who developed SVC syndrome after transvenous pacemaker implantation with complete resolution of the thrombosis after 3 months of oral anticoagulation.

Conclusions

Generally other causes as malignancy are considered to be the most common etiology of SVC syndrome, but benign iatrogenic causes, mainly intravascular devices (central vein catheters, cardiac defibrillators and pacemaker wires), are becoming increasingly common. Procedures performed on venous vasculature, causing a possible intimal injury or vein stenosis, provoked by transvenous leads, seem to be the most reasonable explanation for the observed complication.
Literature
1.
go back to reference Teo N, Sabharwal T, Rowland E, Curry P, Adam A. Treatment of superior vena cava obstruction secondary to pacemaker wires with balloon venoplasty and insertion of metallic stents. Eur Heart J. 2002;23:1465–70.CrossRef Teo N, Sabharwal T, Rowland E, Curry P, Adam A. Treatment of superior vena cava obstruction secondary to pacemaker wires with balloon venoplasty and insertion of metallic stents. Eur Heart J. 2002;23:1465–70.CrossRef
2.
go back to reference Sfyroeras GS, Antonopoulos CN, Mantas G, Moulakakis KG, Kakisis JD, Brountzos E, Lattimer CR, Geroulakos G. A review of open and endovascular treatment of superior vena cava syndrome of benign Aetiology. Eur J Vasc Endovasc Surg 2017;53(2):238–254. doi: https://doi.org/10.1016/j.ejvs.2016.11.013. Epub 2016 Dec 19. PMID: 28007450. Sfyroeras GS, Antonopoulos CN, Mantas G, Moulakakis KG, Kakisis JD, Brountzos E, Lattimer CR, Geroulakos G. A review of open and endovascular treatment of superior vena cava syndrome of benign Aetiology. Eur J Vasc Endovasc Surg 2017;53(2):238–254. doi: https://​doi.​org/​10.​1016/​j.​ejvs.​2016.​11.​013. Epub 2016 Dec 19. PMID: 28007450.
3.
go back to reference Picascia O, Fiorini V, Vitale G, Quassone P, Scognamiglio M, Ferrandino G, Pelella I, Rosano N, De Simone F, Sarti G, Camocardi A, Tamburrini S, Marano I. Iatrogenic superior vena cava syndrome with concomitant deep vein thrombosis of azygos and hemiazygos veins. Radiol Case Rep. 2021;16(7):1895–1898. doi: https://doi.org/10.1016/j.radcr.2021.04.061. PMID: 34113414; PMCID: PMC8170043. Picascia O, Fiorini V, Vitale G, Quassone P, Scognamiglio M, Ferrandino G, Pelella I, Rosano N, De Simone F, Sarti G, Camocardi A, Tamburrini S, Marano I. Iatrogenic superior vena cava syndrome with concomitant deep vein thrombosis of azygos and hemiazygos veins. Radiol Case Rep. 2021;16(7):1895–1898. doi: https://​doi.​org/​10.​1016/​j.​radcr.​2021.​04.​061. PMID: 34113414; PMCID: PMC8170043.
6.
go back to reference Montiel FS, Ghazvinian R, Gottsäter A, Elf J. Treatment with direct oral anticoagulants in patients with upper extremity deep vein thrombosis. Thromb J. 2017;15:26.CrossRef Montiel FS, Ghazvinian R, Gottsäter A, Elf J. Treatment with direct oral anticoagulants in patients with upper extremity deep vein thrombosis. Thromb J. 2017;15:26.CrossRef
Metadata
Title
Superior vena cava syndrome after pacemaker implantation treated with direct oral anticoagulation
Authors
Nicola Mumoli
Antonino Mazzone
Isabella Evangelista
Marco Cei
Alessandra Colombo
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Thrombosis Journal / Issue 1/2021
Electronic ISSN: 1477-9560
DOI
https://doi.org/10.1186/s12959-021-00321-7

Other articles of this Issue 1/2021

Thrombosis Journal 1/2021 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.